dc.contributor.author
Casadó, Vicent
dc.contributor.author
Casadó Anguera, Verònica
dc.date.accessioned
2026-01-21T20:01:42Z
dc.date.available
2026-01-21T20:01:42Z
dc.date.issued
2026-01-20T14:43:27Z
dc.date.issued
2026-01-20T14:43:27Z
dc.date.issued
2023-08-12
dc.date.issued
2026-01-20T14:43:27Z
dc.identifier
https://hdl.handle.net/2445/225834
dc.identifier.uri
https://hdl.handle.net/2445/225834
dc.description.abstract
G protein-coupled receptors (GPCRs) constitute a superfamily of membrane proteins which have in common the presence of 7 transmembrane α-helices linked by several intra- and extracellular loops. This particular structure is important for extracellular stimulus recognition through the amino acids forming the extracellular loops (class B, C and F of GPCRs) or by the transmembrane α-helices (class A and B of GPCRs). Their structure is also essential for signal transduction via intracellular proteins (G proteins, arrestins and kinases – GRKs-) [Citation1]. These proteins are attached to the intracellular loops and/or to the intracellular regions of the α-helices of the GPCRs, even when they are not activated by extracellular ligands or drugs.
dc.format
application/pdf
dc.publisher
Informa Healthcare
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1080/17460441.2023.2216014
dc.relation
Expert Opinion on Drug Discovery, 2023, vol. 18, num.8, p. 815-820
dc.relation
https://doi.org/10.1080/17460441.2023.2216014
dc.rights
(c) Informa Healthcare, 2023
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Enzims al·lostèrics
dc.subject
Allosteric enzymes
dc.title
What are the current trends in G protein-coupled receptor targeted drug discovery?
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion